PTC Therapeutics, Inc. (PTCT) stock
PTCTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 5/3029% above fair value
$60.23−0.13 (-0.22%)
Close on Nov 18, 2026Market cap $5.03BP/E –Yield –
PTC Therapeutics free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
PTC Therapeutics's free cash flow for the twelve months ending Sep 30, 2026 was $2.07M, down 99.7% year over year. For fiscal 2025 it was $702.34M. The highest annual figure on record is $702.34M in fiscal 2025.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $702.34M | – |
| FY2024 | Dec 31, 2024 | -$114.19M | – |
| FY2023 | Dec 31, 2023 | -$186.86M | – |
| FY2022 | Dec 31, 2022 | -$388.67M | – |
| FY2021 | Dec 31, 2021 | -$279.55M | – |
| FY2020 | Dec 31, 2020 | -$211.91M | – |
| FY2019 | Dec 31, 2019 | -$112.40M | – |
| FY2018 | Dec 31, 2018 | -$34.74M | – |
| FY2017 | Dec 31, 2017 | -$13.16M | – |
| FY2016 | Dec 31, 2016 | -$105.34M | – |
| FY2015 | Dec 31, 2015 | -$127.06M | – |
| FY2014 | Dec 31, 2014 | -$61.94M | – |
| FY2013 | Dec 31, 2013 | -$47.77M | – |
| FY2012 | Dec 31, 2012 | -$48.12M | – |
| FY2011 | Dec 31, 2011 | -$20.93M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$27.97M | – |
| Q2 FY2026 | Jun 30, 2026 | $126.92M | – |
| Q1 FY2026 | Mar 31, 2026 | -$60.24M | -106.9% |
| Q4 FY2025 | Dec 31, 2025 | -$36.65M | – |
| Q3 FY2025 | Sep 30, 2025 | -$69.82M | – |
| Q2 FY2025 | Jun 30, 2025 | -$59.58M | – |
| Q1 FY2025 | Mar 31, 2025 | $868.38M | +1319.5% |
| Q4 FY2024 | Dec 31, 2024 | -$33.77M | – |
| Q3 FY2024 | Sep 30, 2024 | -$77.51M | – |
| Q2 FY2024 | Jun 30, 2024 | -$64.08M | – |
| Q1 FY2024 | Mar 31, 2024 | $61.17M | – |
| Q4 FY2023 | Dec 31, 2023 | -$105.85M | – |
| Q3 FY2023 | Sep 30, 2023 | -$20.88M | – |
| Q2 FY2023 | Jun 30, 2023 | -$20.37M | – |
| Q1 FY2023 | Mar 31, 2023 | -$39.76M | – |
| Q4 FY2022 | Dec 31, 2022 | -$174.59M | – |
| Q3 FY2022 | Sep 30, 2022 | -$43.43M | – |
| Q2 FY2022 | Jun 30, 2022 | -$63.94M | – |
| Q1 FY2022 | Mar 31, 2022 | -$106.72M | – |
| Q4 FY2021 | Dec 31, 2021 | -$77.57M | – |
| Q3 FY2021 | Sep 30, 2021 | -$57.03M | -344.2% |
| Q2 FY2021 | Jun 30, 2021 | -$39.12M | – |
| Q1 FY2021 | Mar 31, 2021 | -$105.83M | – |
| Q4 FY2020 | Dec 31, 2020 | -$70.72M | – |
| Q3 FY2020 | Sep 30, 2020 | $23.35M | – |
| Q2 FY2020 | Jun 30, 2020 | -$76.97M | – |
| Q1 FY2020 | Mar 31, 2020 | -$87.58M | – |
| Q4 FY2019 | Dec 31, 2019 | -$14.86M | – |
| Q3 FY2019 | Sep 30, 2019 | -$19.76M | -1052.0% |
| Q2 FY2019 | Jun 30, 2019 | -$32.51M | – |
| Q1 FY2019 | Mar 31, 2019 | -$45.27M | – |
| Q4 FY2018 | Dec 31, 2018 | -$19.75M | -202.6% |
| Q3 FY2018 | Sep 30, 2018 | $2.08M | – |
| Q2 FY2018 | Jun 30, 2018 | -$705.00K | -105.4% |
| Q1 FY2018 | Mar 31, 2018 | -$16.36M | – |
| Q4 FY2017 | Dec 31, 2017 | $19.25M | – |
| Q3 FY2017 | Sep 30, 2017 | -$16.25M | – |
| Q2 FY2017 | Jun 30, 2017 | $12.97M | – |
| Q1 FY2017 | Mar 31, 2017 | -$29.13M | – |
| Q4 FY2016 | Dec 31, 2016 | -$14.56M | – |
See a number that looks wrong?